← Back to All Filings

Abbott Laboratories VP & Controller Disposes of 79 Shares

Low SignificanceSeptember 3, 2026 at 10:41:56 PM UTC

ABBOTT LABORATORIES

$ABT4CIK: 0000001800

Subscribe to track ABT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Insider Transaction Report | Abbott Laboratories ($ABT)

Insider: John A. McCoy, Jr. (VP and Controller) Type: Disposition (Tax Withholding & Sale) Shares Transacted: 79 Total Value: ~$8,696.30 Remaining Direct Holdings: 24,549 shares Filing Date: September 3, 2026 Significance: Low

Comprehensive Analysis

Executive Summary

On September 3, 2026, John A. McCoy, Jr., Vice President and Controller of Abbott Laboratories ($ABT), reported minor dispositions totaling 79 common shares on September 1 and September 2, 2026.

Transaction Breakdown

  • September 1, 2026: Disposed of 52 shares at $110.36 per share ($5,738.72 total) under transaction code F (tax withholding liability).
  • September 2, 2026: Sold 27 shares at $109.54 per share ($2,957.58 total) under transaction code S (open market sale).

Holdings Context

  • Direct Ownership After Transactions: 24,549 shares.
  • Indirect Ownership: 59 shares held indirectly through the Abbott Laboratories Stock Retirement Trust.
  • Market Impact: The aggregate transaction value of $8,696.30 represents an insignificant fraction of total executive holdings and carries minimal market significance.
Topics:#AbbottLaboratories#ABT#InsiderTrading#Form4#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.